Bristol-Myers Squibb, the $20 billion (sales) pharmaceutical giant, has put itself up for sale, according to a news report from Reuters. Itself a product of the 1989 merger of Bristol-Myers and Squibb Corporation, the company is said to be examining a number of options, including a possible combination with GlaxoSmithKline. Click here to read the Reuters report.
Register for Complete Access (Valid Email Required)
By registering on MeetingsNet now, you'll not only unlock thePrinter-friendly, you'll also gain access to exclusive premium content.